ATHERSYS INC (ATHX)

US04744L2051 - Common Stock

0.1018  +0 (+3.77%)

After market: 0.0602 -0.04 (-40.86%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ATHX. ATHX was compared to 592 industry peers in the Biotechnology industry. ATHX has a bad profitability rating. Also its financial health evaluation is rather negative. ATHX does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

ATHX had negative earnings in the past year.
In the past year ATHX has reported a negative cash flow from operations.
ATHX had negative earnings in each of the past 5 years.
In the past 5 years ATHX always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -452.29%, ATHX is doing worse than 97.84% of the companies in the same industry.
Industry RankSector Rank
ROA -452.29%
ROE N/A
ROIC N/A
ROA(3y)-179.33%
ROA(5y)-136.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATHX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

ATHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATHX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ATHX has more shares outstanding
ATHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

ATHX has an Altman-Z score of -107.39. This is a bad value and indicates that ATHX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ATHX (-107.39) is worse than 99.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -107.39
ROIC/WACCN/A
WACC9.64%

2.3 Liquidity

A Current Ratio of 0.09 indicates that ATHX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.09, ATHX is doing worse than 99.50% of the companies in the same industry.
ATHX has a Quick Ratio of 0.09. This is a bad value and indicates that ATHX is not financially healthy enough and could expect problems in meeting its short term obligations.
ATHX's Quick ratio of 0.09 is on the low side compared to the rest of the industry. ATHX is outperformed by 99.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.35% over the past year.
ATHX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.60%.
Measured over the past years, ATHX shows a small growth in Revenue. The Revenue has been growing by 7.52% on average per year.
EPS 1Y (TTM)64.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q72.44%
Revenue 1Y (TTM)-98.6%
Revenue growth 3Y-1.81%
Revenue growth 5Y7.52%
Revenue growth Q2Q-97.84%

3.2 Future

Based on estimates for the next years, ATHX will show a very strong growth in Earnings Per Share. The EPS will grow by 23.63% on average per year.
Based on estimates for the next years, ATHX will show a very negative growth in Revenue. The Revenue will decrease by -25.99% on average per year.
EPS Next Y83.47%
EPS Next 2Y37.18%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

ATHX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATHX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ATHX's earnings are expected to grow with 23.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.18%
EPS Next 3Y23.63%

0

5. Dividend

5.1 Amount

ATHX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATHERSYS INC

NASDAQ:ATHX (10/17/2023, 9:22:18 PM)

After market: 0.0602 -0.04 (-40.86%)

0.1018

+0 (+3.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.29M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -452.29%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)64.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y83.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-98.6%
Revenue growth 3Y-1.81%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y